Evidence map›Paper›PMID 38298513›Full record

ArticleFrontiers in medicine2023

Case presentation and management of Lyme disease patients: a 9-year retrospective analysis in France.

Emeline Perthame, Loïc Chartier, Jean-Claude George, Marie Varloud, Elisabeth Ferquel, Valérie Choumet

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.5field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. A Lyme disease mRNA vaccine targetingMolecular therapy. Nucleic acids · 2025
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Emeline Perthame *Bioinformatics and Biostatistics Hub, Institut Pasteur, Université Paris Cité, Paris, France.
Loïc Chartier *LYSARC, Centre Hospitalier Lyon-Sud, Pierre-Bénite Cedex, France.
Jean-Claude GeorgeGeneral Practitioner, Souilly, France.
Marie VarloudCeva Santé Animale, Libourne, France.
Elisabeth FerquelUnité Environnement et Risques Infectieux, Institut Pasteur, Université Paris Cité, Paris, France.
Valérie ChoumetUnité Environnement et Risques Infectieux, Institut Pasteur, Université Paris Cité, Paris, France.
Université Paris Cité · FRDépartement Santé Animale · FRGénérale de Santé · FRHôpital Lyon Sud · FRInstitut Pasteur · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Lyme borreliosis (LB) is the most common vector disease in temperate countries of the northern hemisphere. It is caused by Methods: To study the case presentation of LB in France, we contacted about 700 physicians every year between 2003 and 2011. An anonymous questionnaire was established allowing the collection of 3,509 cases. The information collected was imported or directly entered into databases and allowed identifying variables that were validated in a multiple correspondence analysis (MCA). Results: Sixty percent of the cases were confirmed, 10% were probable, 13.5% doubtful, 10.2% asymptomatic seropositive and 6.3% were negative. The clinical manifestations reported were cutaneous (63%), neurological (26%), articular (7%), ocular (1.9%) and cardiac (1.3%). Almost all patients were treated. When focusing more particularly on confirmed cases, our studies confirm that children have a distinct clinical presentation from adults. There is a gender effect on clinical presentation, with females presenting more often with erythema migrans or acrodermatitis chronica atrophicans than males, while males present more often with neurological signs or arthritis than females. Discussion: This is the first time that a comprehensive study of suspected Lyme borreliosis cases has been conducted over several years in France. Although we were not able to follow the clinical course of patients after treatment, these results suggest the interest of refining the questionnaire and of following up a cohort of patients over a sufficiently long period to obtain more information on their fate according to different parameters.

Indexed as

epidemiologyFranceLyme borreliosisLyme diseasemultiple correspondence analysisprevalencesymptoms

Identifiers

PMID38298513
PMCPMC10829333
OpenAlexW4390954690

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.